Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Diabetes Metab Syndr ; 13(1): 312-316, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30641718

RESUMEN

BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a serine protease and a secreted protein which increases cholesterol levels in plasma via inducing degradation of low-density lipoprotein receptor (LDLR). Cluster of differentiation 36 (CD36) is a member of a family of cell surface proteins in many cells. CD36 is known as fatty acid translocase (FAT) because it imports fatty acids inside cells and participate in triglyceride storage. It has been suggested that PCSK9 regulates CD36 in some tissues. METHODS: Data and serum levels of TSH, FT4, lipid profile and PCSK9 and the expression of CD36 on monocytes from 40 new untreated patients with subclinical hypothyroidism (SH) and 40 age- sex- and BMI-matched euthyroid controls were analyzed in a cross-sectional study. Then the relationships between these parameters were examined. RESULTS: Patients with SH had higher TSH, FT4, total cholesterol (TC) and triglyceride (TG) Low-density lipoprotein (LDL) and PCSK9 levels than controls. There were significant and positive correlations between serum TSH levels and lipid parameters except HDL-C. PCSK9 had a significant and negative correlation with FT4. No significant correlation could be found in relation to PCSK9 and CD36. CONCLUSIONS: PCSK9 inhibitors are used to reduce blood cholesterol levels as drugs. If it will be proven that PCSK9 can induce CD36 degradation, taking these drugs may have unwanted side effects. This study showed that serum PCSK9 and lipid profile levels increase in patients with subclinical hypothyroidism and there is no relationship between PCSK9 and CD36 in these patients.


Asunto(s)
Biomarcadores/sangre , Antígenos CD36/sangre , Colesterol/sangre , Hipotiroidismo/sangre , Lípidos/sangre , Monocitos/metabolismo , Proproteína Convertasa 9/sangre , Adolescente , Adulto , Estudios de Casos y Controles , Estudios Transversales , Femenino , Estudios de Seguimiento , Humanos , Hipotiroidismo/patología , Masculino , Persona de Mediana Edad , Monocitos/patología , Pronóstico , Receptores de LDL/sangre , Adulto Joven
2.
Int J Biol Macromol ; 123: 682-690, 2019 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-30447374

RESUMEN

The aim of this study was to improvement of adsorption capacity of porous starch (PS) by incorporation of halloysite nanotube (HNT). PS/HNT carrier was synthesized through the solvent exchange method. Various fabrication approaches for PS were introduced and different ethanol ratio (40, 60, 80, 100%), HNT concentration (0, 0.1, 0.2, 0.3, 0.4 and 0.5 mg/mL) and drying method (oven, freeze dryer and microwave) were applied. The results indicated that high ratio of ethanol created larger pores and also the best results were obtained from freeze-dried samples (p < 0.05). Incorporation of HNT could further improve the adsorption capacity. However, the best oil and water adsorption capacity were related to PS alone. The nitrogen adsorption-desorption measurement and scanning electron microscopy elucidated the porous structure of samples. The experimental data were fitted successfully by the Langmuir model rather than Freundlich isotherm. Also PS/HNT had higher apparent density and more negative zeta potential rather than PS. However, the DSC results showed the similar thermal patterns for PS and PS/HNT.


Asunto(s)
Arcilla/química , Nanotubos/química , Almidón/química , Adsorción , Silicatos de Aluminio/química , Microscopía Electrónica de Rastreo , Porosidad , Solventes/química , Termodinámica , Agua/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA